Cooperative antitumor and antiangiogenic activity after oral administration of a novel taxane, an antisense targeting protein kinase A and the EGF receptor inhibitor Iressa

These results provide the first demonstration of the cooperative antitumor activity of three novel agents blocking multiple signaling pathways